2 min read
FDA appoints former AI exec Rick Abramson to lead digital health center
FDA names Rick Abramson, ex-AI health exec, to lead its digital health center as it rethinks AI regulation.
3 articles
FDA names Rick Abramson, ex-AI health exec, to lead its digital health center as it rethinks AI regulation.
AI improves cancer detection in cytology, overcoming human subjectivity and workforce shortages.
DeepRare is an AI system using large language models to diagnose rare diseases. It analyzes patient data to suggest ranked diagnoses with evidence, outperforming existing methods and showing high accuracy in global tests.